Involvement of adenosine A3 receptors in the chemotactic navigation of macrophages towards apoptotic cells

Immunology Letters

Volumn 183, Issue , 2017, Pages 62-72

  Joós, Gergely ^a   Jákim, Judit ^b   Kiss, Beáta ^a   Szamosi, Regina ^b   Papp, Tamás ^c   Felszeghy, Szabolcs ^c   Sághy, Tibor ^a   Nagy, Gábor ^b   Szondy, Zsuzsa ^a  

^a Research Center of Molecular Medicine   (Hungary)

^b Faculty of Science and Technology   (Hungary)

^c UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Adenosine; Adenosine A3 receptor; Apoptotic thymocyte; Chemotactic migration; Macrophage

Indexed keywords

ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A3 RECEPTOR; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; APYRASE; DEXAMETHASONE; ADENOSINE; ADENOSINE A2A RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CHEMOTAXIS; CONTROLLED STUDY; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PROTEIN DEPLETION; SIGNAL TRANSDUCTION; THYMOCYTE; ANIMAL; DRUG EFFECTS; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; NEUTROPHIL CHEMOTAXIS; PERITONEUM MACROPHAGE; THYMUS;

ADENOSINE; ANIMALS; APOPTOSIS; APYRASE; AUTOCRINE COMMUNICATION; CHEMOTAXIS, LEUKOCYTE; DEXAMETHASONE; MACROPHAGES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, KNOCKOUT; PHAGOCYTOSIS; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A3; SIGNAL TRANSDUCTION; THYMOCYTES; THYMUS GLAND;

EID: 85012233026     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2017.02.002     Document Type: Article

References (44)

1. [1] Savill, J., Fadok, V., Henson, P., Haslett, C., Phagocyte recognition of cells undergoing apoptosis. Immunol. Today 14 (1993), 131–136.
2. [2] Surh, C.D., Sprent, J., T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372 (1994), 100–103.
3. [3] Hochreiter-Hufford, A., Ravichandran, K.S., Clearing the dead: apoptotic cell sensing, recognition, engulfment, and digestion. Cold Spring Harb. Perspect. Biol., 5, 2013, a008748.
4. [4] Odaka, C.M., Mizouchi, T., Macrophages are involved in DNA degradation of apoptotic cells in murine thymus after administration of hydrocortisone. Cell Death Differ. 9 (2002), 104–112.
5. [5] Lauber, K., Bohn, E., Kröber, S.M., Xiao, Y.-J., Blumenthal, S.G., Lindemann, R.K., Marini, P., Wiedig, C., Zobywalski, A., Baksh, S., Xu, Y., Autenrieth, I.B., Schulze-Osthoff, K., Belka, C., Stuhler, G., Wesselborg, S., Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113 (2003), 717–730.
6. [6] Hait, N.C., Oskeritzian, C.A., Paugh, S.W., Milstien, S., Spiegel, S., Sphingosine kinases sphingosine 1-phosphate, apoptosis and diseases. Biochim. Biophys. Acta 1758 (2006), 2016–2026.
7. [7] Truman, L.A., Ford, C.A., Pasikowska, M., Pound, J.D., Wilkinson, S.J., Dumitriu, I.E., Melville, L., Melrose, L.A., Ogden, C.A., Nibbs, R., Graham, G., Combadiere, C., Gregory, C.D., CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood 112 (2008), 5026–5036.
8. [8] Elliott, M.R., Chekeni, F.B., Trampont, P.C., Lazarowski, E.R., Kadl, A., Walk, S.F., Park, D., Woodson, R.I., Ostankovich, M., Sharma, P., Lysiak, J.J., Harden, T.K., Leitinger, N., Ravichandran, K.S., Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 461 (2009), 282–286.
9. [9] Heit, B., Tavener, S., Raharjo, E., Kubes, P., An intracellular hierarchy determines direction of migration in opposing chemotactic gradients. J. Cell Biol. 159 (2002), 91–102.
10. [10] Heit, B., Robbins, M., Downey, C.M., Guan, Z., Colarusso, P., Miller, B.J., Jirik, F.R., Kubes, P., PTEN functions to ‘prioritize’ chemotactic cues and prevent ‘distraction’ in migrating neutrophils. Nat. Immunol. 9 (2008), 743–752.
11. 12 receptor agonists are not chemoattractants and macrophage chemotaxis to complement C5a is phosphatidylinositol 3-kinase (PI3K) and p38 mitogen-activated protein kinase (MAPK)-independent. J. Biol. Chem. 286 (2011), 44776–44787.
12. [12] Ridley, A.J., Schwartz, M.A., Burridge, K., Firtel, R.A., Ginsberg, M.H., Borisy, G., Parsons, J.T., Horwitz, A.R., Cell migration: integrating signals from front to back. Science 302 (2003), 1704–1709.
13. [13] Friedl, P., Weigelin, B., Interstitial leukocyte migration and immune function. Nat. Immunol. 9 (2008), 960–969.
14. [14] Kamimura, Y., Xiong, Y., Iglesias, P.A., Hoeller, O., Bolourani, P., Devreotes, P.N., PIP3-independent activation of TorC2 and PKB at the cell's leading edge mediates chemotaxis. Curr. Biol. 18 (2008), 1034–1043.
15. [15] Chen, Y., Corriden, R., Inoue, Y., Yip, L., Hashiguci, N., Zinkernagel, A., Nizet, V., Insel, P.A., Junger, W.G., ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptor. Science 314 (2006), 1792–1795.
16. [16] Butler, M., Sanmugalingam, D., Burton, V.J., Wilson, T., Pearson, R., Watson, R.P., Smith, P., Parkinson, S.J., Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo. Eur. J. Immunol. 42 (2012), 3358–3368.
17. [17] Kronlage, M., Song, J., Sorokin, L., Isfort, K., Schwerdtle, T., Leipziger, J., Robaye, B., Conley, P.B., Kim, H.C., Sargin, S., Schön, P., Schwab, A., Hanley, P.J., Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci. Signal., 3, 2010, ra55.
18. [18] Fredholm, B.B., Ijzerman, A.P., Jacobson, K.A., Linden, J., Müller, C.E., International Union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors–an update. Pharmacol. Rev. 63 (2011), 1–34.
19. [19] Fredholm, B.B., Irenius, E., Kull, B., Schulte, G., Comparison of the potency of adenosine as an agonist at human adenosine receptors expressed in Chinese hamster ovary cells. Biochem. Pharmacol. 61 (2001), 443–448.
20. [20] Ledent, C., Vaugeois, J.M., Schiffmann, S.N., Pedrazzini, T., El Yacoubi, M., Vanderhaeghen, J.J., Costentin, J., Heath, J.K., Vassart, G., Parmentier, M., Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388 (1997), 674–678.
21. [21] Lee, H.T., Ota-Setlik, A., Xu, H., D'Agati, V.D., Jacobson, M.A., Emala, C.W., A3 adenosine receptor knockout mice are protected against ischemia- and myoglobinuria-induced renal failure. Am. J. Physiol. Ren. Physiol. 284 (2003), F267–F273.
22. [22] Nagy, G., Király, G., Turani, M., Bánfalvi, G., Cell trivision of hyperploid cells. DNA Cell Biol. 32 (2013), 676–684.
23. [23] Duró, E., Pallai, A., Köröskényi, K., Sarang, Z., Szondy, Z., Adenosine A3 receptors negatively regulate the engulfment-dependent apoptotic cell suppression of inflammation. Immunol. Lett. 162 (2014), 292–301.
24. [24] Ring, S., Pushkarevskaya, A., Schild, H., Probst, H.C., Jendrossek, V., Wirsdörfer, F., Ledent, C., Robson, S.C., Enk, A.H., Mahnke, K., Regulatory T cell-derived adenosine induces dendritic cell migration through the Epac-Rap1 pathway. J. Immunol. 194 (2015), 3735–3744.
25. [25] Cuenda, A., Rousseau, S., p38 MAP-Kinases pathway regulation, function and role in human diseases. Biochim. Biophys. Acta 1773 (2007), 1358–1375.
26. [26] Jones, G.E., Cellular signaling in macrophage migration and chemotaxis. J. Leukoc. Biol. 68 (2000), 593–602.
27. i-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood 105 (2005), 1127–1134.
28. [28] Rosen, H., Gonzalez-Cabrera, P.J., Sanna, M.G., Brown, S., Sphingosine 1-phosphate receptor signaling. Annu. Rev. Biochem. 78 (2009), 743–768.
29. [29] Gevrey, J.C., Isaac, B.M., Cox, D., Syk is required for monocyte/macrophage chemotaxis to CX3CL1 (Fractalkine). J. Immunol 175 (2005), 3737–3745.
30. 3CR1-mediated activation of the mitogen-activated protein kinase cascade. J. Biol. Chem. 276 (2001), 31831–31838.
31. 3 receptor-mediated regulation of p38 and extracellular-regulated kinase ERK1/2 via phosphatidylinositol-3′-kinase. Biochem. Pharmacol. 67 (2004), 129–134.
32. [32] Aheme, C.M., Kewley, E.M., Eltzschig, H.K., The resurgence of A2B adenosine receptor signaling. Biochim. Biophys. Acta 1808 (2011), 1329–1339.
33. [33] Yamaguchi, H., Maruyama, T., Urade, Y., Nagata, S., Immunosuppression via adenosine receptor activation by adenosine monophosphate released from apoptotic cells. Elife, 3, 2014, e02172.
34. [34] Köröskényi, K., Duró, E., Pallai, A., Sarang, Z., Kloor, D., Ucker, D.S., Beceiro, S., Castrillo, A., Chawla, A., Ledent, C.A., Fésüs, L., Szondy, Z., Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. J. Immunol 186 (2011), 7144–7155.
35. [35] Sándor, K., Pallai, A., Duró, E., Legendre, P., Couillin, I., Sághy, T., Szondy, Z., Adenosine produced from adenine nucleotides through an interaction between apoptotic cells and engulfing macrophages contributes to the appearance of transglutaminase 2 in dying thymocytes. Amino Acids 115 (2017), 124–132.
36. [36] Montalbán Del Barrio, I., Penski, C., Schlahsa, L., Stein, R.G., Diessner, J., Wöckel, A., Dietl, J., Lutz, M.B., Mittelbronn, M., Wischhusen, J., Häusler, S.F., Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages − a self-amplifying CD39- and CD73-dependent mechanism for tumor immune escape. J. Immunother. Cancer, 4, 2016, 49.
37. [37] Koszałka, P., Gołuńska, M., Stanisławowski, M., Urban, A., Stasiłojć, G., Majewski, M., Wierzbicki, P., Składanowski, A.C., Bigda, J., CD73 on B16F10 melanoma cells in CD73-deficient mice promotes tumor growth angiogenesis, neovascularization, macrophage infiltration and metastasis. Int. J. Biochem. Cell Biol. 69 (2015), 1–10.
38. [38] Koszałka, P., Gołuńska, M., Urban, A., Stasiłojć, G., Stanisławowski, M., Majewski, M., Składanowski, A.C., Bigda, J., Specific activation of A3, A2A and A1 adenosine receptors in CD73-knockout mice affects B16F10 melanoma growth, neovascularization, angiogenesis and macrophage infiltration. PLoS One, 11, 2016, e0151420.
39. [39] Rezzani, R., Bonomini, F., Rodella, L.F., Histochemical and molecular overview of the thymus as site for T-cells development. Prog. Histochem. Cytochem. 43 (2008), 73–120.
40. [40] McColl, A., Bournazos, S., Franz, S., Perretti, M., Morgan, B.P., Haslett, C., Dransfield, I., Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J. Immunol. 183 (2009), 2167–2175.
41. [41] Garabuczi, É., Sarang, Z., Szondy, Z., Glucocorticoids enhance prolonged clearance of apoptotic cells by upregulating liver X receptor, peroxisome proliferator-activated receptor-δ and UCP2. Biochim. Biophys. Acta 1853 (2015), 573–582.
42. [42] Huber, J., Vales, A., Mitulovic, G., Blumer, M., Schmid, R., Witztum, J.L., Binder, B.R., Leitinger, N., Oxidized membrane vesicles and blebs from apoptotic cells contain biologically active oxidized phospholipids that induce monocyte-endothelial interactions. Arterioscler. Thromb. Vasc. Biol. 22 (2002), 101–107.
43. [43] Szondy, Z., Molnar, P., Nemes, Z., Boyiadzis, M., Kedei, N., Tóth, R., Fésüs, L., Differential expression of tissue transglutaminase during in vivo apoptosis of thymocytes induced via distinct signalling pathways. FEBS Lett. 404 (1997), 307–313.
44. [44] Resta, R., Hooker, S.W., Laurent, A.B., Jamshedur Rahman, S.M., Franklin, M., Knudsen, T.B., Nadon, N.L., Thompson, L.F., Insights into thymic purine metabolism and adenosine deaminase deficiency revealed by transgenic mice overexpressing ecto-5′-nucleotidase (CD73). J. Clin. Invest. 99 (1997), 676–683.